1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Letters of intent due April 24, 2026. Full application cycle open for 2026.
"Early State Seed Funding (Gastric Cancer Foundation)" is currently closed and not accepting applications.
Early State Seed Funding is a grant from the Gastric Cancer Foundation that funds promising early-stage research focused on discovering early detection diagnostics and developing innovative therapies for the treatment of gastric (stomach) cancer. Early-stage seed funding enables researchers to generate preliminary data sufficient to apply for larger grants, an area the Foundation has made a special strategic focus.
Recipients receive a one-time grant of up to $100,000. Letters of intent must be submitted by email to grants@gastriccancer. org.
The deadline for letters of intent was April 24, 2026. Eligible applicants are early-career researchers with promising projects in gastric cancer.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gastric Cancer Foundation Early Stage Research Grants | Gastric Cancer Foundation Seed Funding for Early Stage Research The Gastric Cancer Foundation provides early funding for projects that show promise to facilitate the development of new treatments for gastric cancer. Supporting Innovative New Research The application process is now open for 2026 seed grants.
These grants provide early-stage funding for promising studies focused on discovering early detection diagnostics and developing innovative therapies for the treatment of gastric (stomach) cancer. Recipients receive a one-time grant of up to $100,000. Letters of intent should be submitted by email no later than April 24, 2026 to grants@gastriccancer.
org. View Eligibility Criteria and Deadlines Early-stage seed funding is extremely important because it enables researchers to generate sufficient preliminary data to submit compelling and competitive applications for large grants. It is often difficult for researchers to obtain this type of support.
The Gastric Cancer Foundation has made early funding a special focus of its research strategy.
Developing antibody-drug conjugate that targets stomach tumors Pradeep Chaluvally-Raghavan, PhD Medical College of Wisconsin Uncovering how gastric tumors evolve and become resistant to treatment Ignacio Vázquez-García, PhD Massachusetts General Hospital and Harvard Medical School The Novel Functions of WEE1 I Human Gastric Adenocarcinoma University of Miami Miller School of Medicine Dissecting Putative Therapeutic Biomarker Co-expression and Tumor Microenvironment Dynamics in Early-Onset Gastroesophageal Cancers Targeting TGFβ signaling in gastric cancer: A biomarker-driven approach towards clinical translation Case Western Reserve University School of Medicine Targeting claudin 18.
2-expressing gastric cancer using T cell antigen coupler (TAC)-T cells Columbia University Irving Medical Center Identifying and targeting peritoneal-specific immunosuppresive networkls in gastric cancer from patient-derived samples Alexandra-Chloé Villani, PhD Massachusetts General Hospital Pre-clinical project to evaluate the effects of SCD1 inhibition in GCK mouse stomachs and to determine whether the SCD1 inhibition can be a possible therapeutic intervention or treatment in patients with gastric dysplasia or early-stage cancer Vanderbilt University Medical Center The Oral Commensal Bacterium Fusobacterium Nucleatum as a Potential Driver of Gastric Cancer Fred Hutchinson Cancer Research Center Utilization of molecular evaluation of clinically-annotated patient samples and the application of single cell RNA-sequencing to strong in vitro model systems to understand the therapeutic potential of platinum chemotherapy and PARP inhibitors in HR-deficient gastric cancer Dana-Farber/Harvard Cancer Center Targeting Myeloid Cells to Enhance Immune Checkpoint Blockade in Gastric Cancer Exploiting KMT2 as a Predictive Marker and Therapeutic Target in Advanced Gastric Cancer USC Norris Comprehensive Cancer Center New Targets and Therapies for Chromosomal Instability Underlying Gastric Cancer Dana-Farber Cancer Institute Interperitoneal Project to Develop New Therapies for Peritoneal Caricinomatosis MD Anderson Cancer Center Study to Test Effectiveness of Combination Drug Therapy to Target Gastric Cancers with FGFR2 Defect and Prevent Drug Resistance Stanford Genome Technology Center Studying the Gastric Cancer Microenvironment Using Single Cell Genomics Stanford Genome Technology Center Use of Next-Generation DNA Sequencing Technology to Perform Whole-Genome Level Analysis on large Cohort of Individuals with Gastric Cancer Stanford University Medical School $550,000 Total Grants 2010-2015 Making Strategic Investments Toward a Cure Together, we can find a cure for gastric cancer.
Support our critical research studies and patient education initiatives and find your cause for hope.
According to the current listing, eligibility includes: Early-career researchers with promising projects focused on early detection diagnostics and innovative therapies for gastric (stomach) cancer. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 24, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Early State Seed Funding (Gastric Cancer Foundation) is funded by Gastric Cancer Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start with the full solicitation document linked on this page — it contains the submission instructions and required forms.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article